U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07104201) titled 'Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)' on March 24.
Brief Summary: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)
Study Start Date: March 13
Study Type: INTERVENTIONAL
Condition:
Primary Biliary Cholangitis (PBC)
Intervention:
DRUG: Fenofibrate
Fenofibrate 200mg
Recruitment Status: RECRUITING
Sponsor: Xijing Hospital of Digestive Diseases
Information provided by (Responsible Party): Han Ying, Xijing Hospital of Digestive Diseases
Disclaimer: Curated by HT Syndication....